CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

AMGN's Operating Income Growth by Quarter and Year

Amgen Inc 's Operating Income results by quarter and year




AMGN Operating Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 9,139.00 9,674.00 2,382.00
III Quarter September - - - 2,323.00
II Quarter June - - - 2,832.00
I Quarter March 0.00 - - 2,726.00
FY   - 9,139.00 9,674.00 10,263.00



AMGN Operating Income first quarter 2021 Y/Y Growth Comment
Amgen Inc in the first quarter recorded Operating Loss of $ 0.00 millions.

According to the results reported in the first quarter, Amgen Inc achieved the best Operating Income growth in Biotechnology & Drugs industry. While Amgen Inc ' s Operating Income no change of % ranks overall at the positon no. in the first quarter.

Explain Operating Income growth


AMGN Operating Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - -5.53 % 306.13 % 6.1 %
III Quarter September - - - -4.76 %
II Quarter June - - - 4.97 %
I Quarter March - - - 5.21 %
FY   - -5.53 % -5.74 % 2.91 %

Financial Statements
Amgen Inc 's first quarter 2021 Operating Income $ 0.00 millions AMGN's Income Statement
Amgen Inc 's first quarter 2020 Operating Income $ 0.00 millions Quarterly AMGN's Income Statement
New: More AMGN's historic Operating Income Growth >>


AMGN Operating Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - 2.54 %
III Quarter September - - - -17.97 %
II Quarter June - - - 3.89 %
I Quarter March - - - 21.43 %
FY (Year on Year)   - -5.53 % -5.74 % 2.91 %




Operating Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Amgen Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AMGN's I. Quarter Q/Q Operating Income Comment
Current results of 0.00 millions by Amgen Inc look even worse compare to the 9,139.00 millions Operating Loss in the forth quarter.

Within Biotechnology & Drugs industry Amgen Inc achieved highest sequential Operating Income growth. While Amgen Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AMGN's I. Quarter Q/Q Operating Income Comment
I. Quarter 2021 Operating Loss of 0.00 millions by Amgen Inc come out even worse considering the 9,139.00 millions Operating Loss in the previous quarter.

Within Biotechnology & Drugs industry Amgen Inc achieved highest sequential Operating Income growth. While Amgen Inc 's Operating Income growth quarter on quarter, overall rank is .


Amgen Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Operating Income 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
In the Mar 31 2021 period, Amgen Inc 's cumulative trailing twelve month Operating Income remained unchanged compare to the same period a year ago.

Amgen Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
In the Mar 31 2021 period, Amgen Inc 's cumulative trailing twelve month Operating Income remained unchanged compare to the same period a year ago.

Amgen Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
AMGN's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for AMGN's Competitors
Operating Income Growth for Amgen Inc 's Suppliers
Operating Income Growth for AMGN's Customers

You may also want to know
AMGN's Annual Growth Rates AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roe AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio
AMGN's Roa AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2021
National Healthcare Corp-3.69%$ -3.689 millions
Prestige Consumer Healthcare Inc -4.03%$ -4.032 millions
Baxter International Inc -4.65%$ -4.645 millions
Davita Inc -4.89%$ -4.894 millions
Phibro Animal Health Corp-5.57%$ -5.568 millions
Catalyst Pharmaceuticals Inc -8.40%$ -8.400 millions
Alexion Pharmaceuticals Inc -8.53%$ -8.526 millions
Diversified Healthcare Trust-18.14%$ -18.144 millions
Amneal Pharmaceuticals Inc -20.56%$ -20.564 millions
Healthcare Services Group Inc -21.26%$ -21.259 millions
Merck and Co Inc -22.90%$ -22.896 millions
Atrion Corporation-23.76%$ -23.758 millions
Msa Safety Inc-25.08%$ -25.083 millions
Acadia Healthcare Company Inc -26.43%$ -26.425 millions
Eli Lilly And Company-27.38%$ -27.376 millions
Lifevantage Corp-31.16%$ -31.157 millions
Teleflex Incorporated-34.15%$ -34.155 millions
Accuray Incorporated-44.46%$ -44.460 millions
Biogen Inc -46.49%$ -46.486 millions
Neurocrine Biosciences Inc -46.52%$ -46.520 millions
Corcept Therapeutics Inc-47.93%$ -47.925 millions
Vyne Therapeutics Inc -51.29%$ -51.287 millions
Supernus Pharmaceuticals inc -54.45%$ -54.453 millions
Nuvasive Inc-56.43%$ -56.429 millions
Five Star Senior Living Inc -57.53%$ -57.526 millions
The Pennant Group Inc -62.24%$ -62.243 millions
Viemed Healthcare Inc -71.14%$ -71.138 millions
Biomarin Pharmaceutical Inc-76.10%$ -76.100 millions
Anika Therapeutics Inc -82.27%$ -82.267 millions
Protokinetix Incorporated-95.80%$ -95.801 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CNST's Profile

Stock Price

CNST's Financials

Business Description

Fundamentals

Charts & Quotes

CNST's News

Suppliers

CNST's Competitors

Customers & Markets

Economic Indicators

CNST's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071